Novel Drug Delivery Systems Market is estimated to be US$ 13.5 billion by 2030 with a CAGR of 6.1% during the forecast period

 



Novel Drug Delivery System Market accounted for US$ 7.5 billion in 2020 and is estimated to be US$ 13.5 million by 2030 with a CAGR of 6.1% during the forecast period. Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. Various drug delivery and drug targeting systems are currently under development to minimize drug degradation and loss, to prevent harmful side-effects and to increase drug bioavailability and the fraction of the drug accumulated in the required zone.

The report " Global Novel Drug Delivery Systems in Cancer Therapy Market, By Type (Nanoparticles, Liquid Embolics, and Embolization Particles), By Application (Hospitals & Clinic, Cancer Treatment Centers, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”

Key Highlights:

·         In 2021, Germany-based biotech ATAI Life Sciences (Nasdaq: ATAI), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, and UniQuest, Australia’s leading university technology transfer company commercializing the research of The University of Queensland (UQ), announced the launch of InnarisBio Inc, to develop a novel sol-gel intranasal drug delivery technology to improve treatments for mental health disorders.

Analyst View:

Increased requirement for improving the safety, efficacy, and bio-recognition of drugs for disease-specific sites within the body is the major factor driving growth of the global novel drug delivery systems in cancer therapy market. According to World Health Organization, cancer is the second leading cause of death globally and is accounted for 9.6 million deaths in 2018. Technological advances leading to the development of new and innovative therapy is also expected to boost growth of the target market over the forecast period. However, factors such as strict regulatory pathways and high treatment cost associated with NDDS for new product development may hamper global market growth over the forecast period.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2230

 

Key Market Insights from the report:

The Global Novel Drug Delivery System Market accounted for US$ 7.5 billion in 2020 and is estimated to be US$ 13.5 million by 2030 with a CAGR of 6.1% during the forecast period.  The global novel drug delivery systems in cancer therapy market report segments the market on the basis of type, application, and region.

·         On the basis of type, the Global Novel Drug Delivery System Market is segmented into Nanoparticles, Liquid Embolics, and Embolization Particles.

·         On the basis of Application, the target market is segmented into Hospitals & Clinic, Cancer Treatment Centers, and Others.

·         Based on region the Global Novel Drug Delivery System Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The global market in North America region is seen to have a matured growth since this market correlates with the increasing growth rate of cancer.

Competitive Landscape:

The Key players in the Global Novel Drug Delivery System Market includes, Advanced Medical, Isotope Corporation, Eckert & Ziegler BEBIG S.A., Bind Therapeutics, Inc., Polysciences, Inc., Nanobiotix S.A., CeloNova BioSciences, Inc., Covidien plc, EmboMedics, Inc., Cook Medical, Inc., and Mo-Sci Corporation

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

 

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com

 

Comments

Post a Comment

Popular posts from this blog

Patient Portal Market is estimated to be US$ 7862.01 billion by 2030 with a CAGR of 11.50% during the forecast period

Image
  Patient Portal Market  accounted for US$ 2643.21 million in 2020 and is estimated to be US$ 7862.01 million by 2030 and is anticipated to register a CAGR of 11.50%. The patients can share and view their health information and communicate remotely. These characteristics enables patients to look into various data points, such as diagnostic test results, medical history, and prescription information. Patient portal is one of the many tools that allow the healthcare payers and providers to arrive at outcomes, which are patient-centric. Rapid technological advancements in the digital space are rising the engagement level of patients in the entire healthcare ecosystem. Data points collected on a per-patient basis through patient portal can be used for performing pin-point diagnosis, designing better clinical trials, and helping in the elimination of administration of redundant therapies and drugs to individual patients. The report   "   Global Patient Portal Market, By P...
Read more

Nuclear Medicine Market is estimated to be US$ 6.49 billion by 2030 with a CAGR of 4.30% during the forecast period

Image
  The Nuclear Medicine Market accounted for US$ 4.26 billion and is estimated to be US$ 6.49 billion by 2030 with a CAGR of 4.30% during the forecast period. Nuclear medicine may be a medicine involving the appliance of radioactive substances within the diagnosis and treatment of disease. Medicine imaging, during a sense, is "radiology done inside out" or "endoradiology" because it records radiation emitting from within the body instead of radiation that's generated by external sources like X-rays. Additionally, medicine scans differ from radiology, because the emphasis isn't on imaging anatomy, but on the function. For such reason, it's called a physiological imaging modality. Single photon emission computerized tomography (SPECT) and positron emission tomography (PET) scans are the 2 commonest imaging modalities in medicine.   The report "  Global Nuclear Medicine Market, By Diagnostics (Single Photon Emission, Computed Tomography (SPECT), an...
Read more

Knee Replacement Market is estimated to be 14.2 billion by 2029 with a CAGR of 4.3% during the forecasted period.

Image
  knee replacement market  accounted for 9.7 billion in 2020 and is estimated to be US$ 14.2 billion by 2029 and is anticipated to register a CAGR of 4.3%. The report " Global Knee Replacement Market, By Product ( Total Knee Replacement, Partial Knee Replacement, Kneecap Replacement, and Complex (or revision) Knee Replacement),  By End Users ( Hospitals, Orthopedic Centers, and Other ),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In March 2018, Smith and Nephew announced commercial release of bi-cruciate retaining Journey II XR total knee arthroplasty across the U.S. and Japan. The product launch was aimed at capturing large customer base with innovative product offering. In October 2018, Zimmer Biomet Holdings announced to collaborate with Apple to facilitate patient and surgeon connection during the knee and hip replacement procedures. Th...
Read more